Dublin, April 07, 2026 (GLOBE NEWSWIRE) — The “Digital Health Monitoring Devices Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The report offers detailed insights including market size, regional shares, competitive landscape, and future trends.
The digital health monitoring devices market is witnessing remarkable growth, projected to escalate from $7.75 billion in 2025 to $9.4 billion in 2026 at a CAGR of 21.3%. This surge is driven by numerous factors including the increasing prevalence of chronic diseases, expanding mobile health applications, and growing adoption of wireless monitoring devices, along with enhanced access to digital healthcare infrastructure.
Forecasts indicate that the market will reach $20.33 billion in 2030, mirroring a CAGR of 21.3%. This growth will be fueled by increased telehealth investments, a heightened focus on preventive healthcare, the proliferation of AI-enabled health analytics, the rise of personalized healthcare solutions, and the integration of digital health with clinical workflows. Contributing trends include the growing adoption of remote patient monitoring devices and wearable health technologies, alongside the integration of cloud-based health platforms and continuous health data tracking.
The burgeoning demand for remote monitoring devices is a significant growth driver. These devices allow healthcare professionals to efficiently gather and evaluate patient data. For instance, the UK Parliament expanded digital systems to monitor vital signs for 500,000 more individuals in care settings as of March 2023. This increasing demand underscores the growth trajectory of the digital health monitoring devices market.
Technological innovation remains pivotal in this sector. In June 2024, Prevounce Health unveiled the Pylo GL1-LTE, a remote blood glucose monitoring device that integrates seamlessly with the Prevounce remote care management platform and ensures reliable data transmission across diverse cellular networks in the U.S. This innovation supports the expanding landscape of remote patient monitoring (RPM) programs for diabetes management.
In a significant industry move, Becton, Dickinson and Company acquired the Critical Care product group from Edwards Lifesciences in September 2024. This acquisition enriches BD’s portfolio with cutting-edge monitoring technologies, including AI-powered clinical decision-making tools.
Key players in this market include Philips Healthcare, Medtronic, GE Healthcare, and Abbott Laboratories, among others. North America emerged as the leading region in 2025, with significant market shares across regions such as Asia-Pacific, Western Europe, and more.
Reasons to Purchase:
- Gain a global perspective with comprehensive coverage across 16 geographies.
- Assess macro factors impacting markets, including geopolitical conflicts, trade policies, and regulatory changes.
- Develop effective regional and country strategies using localized data.
- Identify profitable growth segments to target investment strategies.
- Utilize forecast data to outperform competitors and keep abreast of market dynamics.
- Understand consumer behavior through detailed end-user analysis.
- Benchmark performance against competitors, assessing market share and innovation.
- Measure market potential with total addressable market (TAM) analysis and market attractiveness scoring.
- Support presentations with high-quality data and analysis tailored for both internal and external use.
- Receive updates and data delivered in user-friendly formats for streamlined extraction and analysis.
Markets Covered:
1) By Digital Health Solution Type: Tele-Health; EHR Or EMR; M-Health; Wireless Health; Remote Patient Monitoring
2) By Product Type: Device; Software; Services; Other Product Types
3) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Homecare Settings; Other End-Users
Subsegments:
1) By Tele-Health: Video Consultation Tools; Telemedicine Platforms; Remote Diagnosis Systems
2) By EHR Or EMR: Cloud-Based and On-Premises Solutions; Interoperability Tools
3) By M-Health: Health and Fitness Apps; Mobile Patient Engagement Tools; Medication Management Apps
4) By Wireless Health: Monitoring Devices; Wearable Trackers; Communication Devices
5) By Remote Patient Monitoring: Home Monitoring Devices; Disease Management Tools; Wearable Biosensors
Key Attributes
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2026 – 2030 |
| Estimated Market Value (USD) in 2026 | $9.4 Billion |
| Forecasted Market Value (USD) by 2030 | $20.33 Billion |
| Compound Annual Growth Rate | 21.3% |
| Regions Covered | Global |
The companies featured in this Digital Health Monitoring Devices market report include:
- Philips Healthcare
- Medtronic
- GE Healthcare
- Abbott Laboratories
- Omron Healthcare
- Fitbit (Google)
- Garmin
- Dexcom
- Withings
- Apple Inc.
- Masimo Corporation
- iHealth Labs
- AliveCor
- Qardio
- Huawei Technologies
- Xiaomi Inc.
- Polar Electro
- ResMed
- Nihon Kohden
- Siemens Healthineers
- Mindray
- Spacelabs Healthcare
For more information about this report visit https://www.researchandmarkets.com/r/txjzy8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Digital Health Monitoring Devices Market
